Somewhat Favorable Press Coverage Somewhat Unlikely to Impact Bioamber (NYSE:BIOA) Stock Price

Press coverage about Bioamber (NYSE:BIOA) has been trending somewhat positive on Sunday, according to Accern. The research firm rates the sentiment of media coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Bioamber earned a coverage optimism score of 0.17 on Accern’s scale. Accern also gave press coverage about the biotechnology company an impact score of 47.3833869937947 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

Here are some of the media headlines that may have effected Accern Sentiment Analysis’s rankings:

How to Become a New Pot Stock Millionaire

BIOA opened at $0.04 on Friday. Bioamber has a 52 week low of $0.03 and a 52 week high of $2.88. The company has a debt-to-equity ratio of 0.24, a current ratio of 1.08 and a quick ratio of 0.75.

A number of research firms have recently issued reports on BIOA. Zacks Investment Research cut shares of Bioamber from a “hold” rating to a “sell” rating in a research note on Tuesday, January 2nd. ValuEngine cut shares of Bioamber from a “hold” rating to a “sell” rating in a research report on Thursday, March 1st. Finally, HC Wainwright dropped their price objective on shares of Bioamber from $12.00 to $1.75 and set a “buy” rating for the company in a research report on Thursday, March 29th.

WARNING: This piece was first published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this piece on another site, it was copied illegally and republished in violation of US and international trademark & copyright laws. The correct version of this piece can be accessed at https://www.dispatchtribunal.com/2018/04/08/bioamber-bioa-receiving-somewhat-favorable-media-coverage-study-shows.html.

Bioamber Company Profile

BioAmber Inc (BioAmber), formerly DNP Green Technology, Inc, is an industrial biotechnology company, which produces sustainable chemicals. The Company’s technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstocks into sustainable chemicals that are replacements for petroleum-derived chemicals, which are used in a range of everyday products, including plastics, food additives and personal care products.

Insider Buying and Selling by Quarter for Bioamber (NYSE:BIOA)

Receive News & Ratings for Bioamber Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioamber and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply